Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125317363 | 12531736 | 3 | F | 2004 | 20160629 | 20160706 | 20160808 | EXP | US-ASTRAZENECA-2016SE71217 | ASTRAZENECA | 53.00 | YR | F | Y | 0.00000 | 20160808 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125317363 | 12531736 | 1 | PS | FASLODEX | FULVESTRANT | 1 | Intramuscular | DOSE AND FREQUENCY UNKNOWN | 21344 | INJECTION | |||||||||
| 125317363 | 12531736 | 2 | SS | TAMOXIFEN | TAMOXIFEN | 1 | Oral | DOSE AND FREQUENCY UNKNOWN | 0 | TABLET | |||||||||
| 125317363 | 12531736 | 3 | SS | FEMARA | LETROZOLE | 1 | Unknown | 2.5 GENERIC | U | U | 0 | ||||||||
| 125317363 | 12531736 | 4 | SS | FEMARA | LETROZOLE | 1 | Unknown | 2.5 BRAND | U | U | 0 | ||||||||
| 125317363 | 12531736 | 5 | SS | IBRANCE | PALBOCICLIB | 1 | Oral | 125.0MG UNKNOWN | 0 | 125 | MG | CAPSULE | |||||||
| 125317363 | 12531736 | 6 | SS | ZOMETA | ZOLEDRONIC ACID | 1 | Unknown | MONTHLY | 0 | INTRAVENOUS INFUSION | |||||||||
| 125317363 | 12531736 | 7 | C | XANAX | ALPRAZOLAM | 1 | 1 MG | 0 | |||||||||||
| 125317363 | 12531736 | 8 | C | ADDERALL XR | AMPHETAMINE ASPARTATEAMPHETAMINE SULFATEDEXTROAMPHETAMINE SACCHARATEDEXTROAMPHETAMINE SULFATE | 1 | 30 MG | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125317363 | 12531736 | 3 | Bone metabolism disorder |
| 125317363 | 12531736 | 4 | Bone metabolism disorder |
| 125317363 | 12531736 | 5 | Bone metabolism disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125317363 | 12531736 | OT |
| 125317363 | 12531736 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125317363 | 12531736 | Arthralgia | |
| 125317363 | 12531736 | Bone lesion | |
| 125317363 | 12531736 | Bone metabolism disorder | |
| 125317363 | 12531736 | Bone neoplasm | |
| 125317363 | 12531736 | Breast mass | |
| 125317363 | 12531736 | Chills | |
| 125317363 | 12531736 | Diarrhoea | |
| 125317363 | 12531736 | Fatigue | |
| 125317363 | 12531736 | Headache | |
| 125317363 | 12531736 | Muscle spasms | |
| 125317363 | 12531736 | Pulmonary pain | |
| 125317363 | 12531736 | Pyrexia | |
| 125317363 | 12531736 | Withdrawal syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125317363 | 12531736 | 1 | 201509 | 0 | ||
| 125317363 | 12531736 | 2 | 2004 | 0 | ||
| 125317363 | 12531736 | 3 | 201601 | 201605 | 0 | |
| 125317363 | 12531736 | 4 | 201605 | 0 | ||
| 125317363 | 12531736 | 5 | 201601 | 0 | ||
| 125317363 | 12531736 | 6 | 201501 | 201509 | 0 |